Table 2 Significant regions
From: Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
cytoBand (+ gain, - loss) | Mbp startPos (BAC) | Mbp endPos (BAC) | Size (Mbp) | cases resistant (%) | cases sensitive (%) | P-value | No. of genes |
|---|---|---|---|---|---|---|---|
+ 3q26.2 | 170150001 (RP11-152C17) | 170300002 (RP11-252J1) | 0.15 | 65 | 20 | 0.0095 | 2 |
- 6q11.2-12 | 63400001 (RP11-692G18) | 68250002 (RP11-164N24) | 4.85 | 40 | 0 | 0.0033 | 16 |
- 9p22.3 | 15100001 (RP11-271D19) | 16150002 (RP11-141K7) | 1.05 | 45 | 5 | 0.0084 | 6 |
- 9p22.2-22.1 | 17750001 (RP11-601F21) | 18550002 (RP11-269F13) | 0.8 | 45 | 5 | 0.0084 | 2 |
- 9p22.1-21.3 | 19650001 (RP11-61D22) | 20800002 (RP11-66P3) | 1.15 | 45 | 5 | 0.0084 | 3 |
- Xp22.2-22.12 | 15250001 (RP11-438H12) | 20750002 (RP11-451E9) | 5.5 | 60-65 | 15 | 0.0031-0.0079 | 39 |
- Xp22.11-11.3 | 24050001 (RP11-79B3) | 46900002 (RP11-571E6) | 22.85 | 60-70 | 15-20 | 0.00077-0.0095 | 141 |
- Xp11.23-11.1 | 49250001 (RP11-122N23) | 58250002 (RP11-96A5) | 9 | 60-65 | 10-15 | 0.00077-0.0079 | 85 |